Molecular Pharmaceutics · 2018 · 48 citations · 51 references
Natural SciencesMedicinal ChemistryPharmacologyChemotherapyDrug DeliveryPolymer ChemistryCancer NanomedicineNanomedicinePolymer StructurePolymeric Drug Delivery SystemsPolymeric NanomaterialsPolymerization ChemistryDrug-polymer ConjugationNanostructuresPolymer - Drug ConjugatesPolymer ConjugatesPolymer-drug ConjugationPolymeric ConjugatesRandom CopolymersReversible Addition-fragmentation Chain Transfer Polymerization
A series of polymer-drug conjugates based on 2-methacryloyloxyethyl phosphorylcholine (MPC) was prepared with the glioblastoma drug temozolomide (TMZ) as pendent groups. Random and block copolymers were synthesized by reversible addition-fragmentation chain-transfer (RAFT) polymerization using a TMZ-containing methacrylate monomer. The solution properties of the polyMPC-TMZ copolymers were investigated by dynamic light scattering and transmission electron microscopy, revealing well-defined nanostructures from the block copolymers. Conjugation of TMZ to polyMPC enhanced drug stability, with decomposition half-life values ranging from 2- to 19-times longer than that of free TMZ. The cytotoxicity of polyMPC-TMZ was evaluated in both chemosensitive (U87MG) and chemoresistant (T98G) glioblastoma cell lines. Furthermore, the polyMPC-TMZ platform was expanded considerably by the preparation of redox-sensitive polyMPC-TMZ copolymers utilizing disulfides as the polymer-to-drug linker.
51
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Lifeng Zhang, Adi Eisenberg · Journal of the American Chemical Society · 1996 · 1.3K citations